Susan G. Komen for the Cure CEO Hala Moddelmog testified before a special hearing of the Senate Committee on Health, Education, Labor and Pensions on the need for comprehensive legislation to address the nation's cancer crisis. Along with Moddeling at the committee meeting was Elizabeth Edwards and Lance Armstrong. Moddeling, in her testimony, emphasized the [...]
Prostate cancer preferentially metastasizes to bone and the mortality from prostate cancer is 70% once bone metastases are present. In addition, prostate cancer-induced bone metastases are associated with significant complications including severe pain, skeletal fractures, spinal cord compression and bone marrow suppression. Most doctors structure their treatment protocols against bone metastases by treating the cancer [...]
Watson Pharmaceuticals, Inc. (WPI), announced that the U.S. Food and Drug Administration (FDA) has approved MIXJECT, which is a new delivery system for TRELSTAR (triptorelin pamoate for injectable suspension). The delivery system includes some new features, a smaller 21-gauge needle that should improve comfort and a shield covering the needle both before and after drug [...]
At the recent American Association of Cancer Researchers (AACR,) there was a shocking poster presentation that demonstrated that mice that exercised experienced implanted prostate cancer tumor grow that was twice as fast than did those mice who were restricted from exercising! The study was conducted by the Duke Comprehensive Cancer Center (DCCC) and the Duke [...]
According to a report from Japan in the March issue of "Cancer Epidemiology, Biomarkers & Prevention", dietary isoflavones may reduce the risk of initially developing localized prostate cancer, but appear to be associated with advanced disease when prostate cancer does occur. This would explain the prior studies in which the consumption of soy by Japanese [...]